Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Gueiderikh, A."'
Autor:
Xavier Renaudin, Baraah Al Ahmad Nachar, Benedetta Mancini, Anna Gueiderikh, Noémie Louis-Joseph, Frédérique Maczkowiak-Chartois, Filippo Rosselli
Publikováno v:
PLoS Genetics, Vol 20, Iss 11, p e1011474 (2024)
Abnormal expression of the cell cycle inhibitor and p53 target CDKN1A/p21 has been associated with paradoxical outcomes, such as hyperproliferation in p53-deficient cancer cells or hypoproliferation that affects hematopoietic stem cell behavior, lead
Externí odkaz:
https://doaj.org/article/40e7e2b7a58643aaab9c95cae7040ae7
Autor:
Anna Gueiderikh, Jérémy Baude, David Baron, Renaud Schiappa, Sandrine Katsahian, Damien Moreau, Marc Laurans, Jean-Emmanuel Bibault, Sarah Kreps, Pierre-Yves Bondiau, Magali Quivrin, Alexis Lépinoy, David Pasquier, Jean-Michel Hannoun-Levi, Philippe Giraud
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundNodes are the second site for prostate cancer recurrence. Whole-pelvic radiotherapy (WPRT) has shown superiority over nodal stereotactic body radiotherapy (SBRT) in two retrospective cohorts. We aimed to compare both modalities and assess f
Externí odkaz:
https://doaj.org/article/09d0d3c509a740dfbe17752833486e99
Autor:
A. Gueiderikh, A. Tarabay, M. Abdelouahab, C. Smolenschi, M. L. Tanguy, M. Valery, D. Malka, T. Pudlarz, A. Fuerea, V. Boige, A. Hollebecque, M. Ducreux, A. Boilève
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) primarily relies on FOLFIRINOX (LV5FU- irinotecan – Oxaliplatine) and Gemcitabine – Nab-Paclitaxel in the first-line setting. However, second-lines remain less well-
Externí odkaz:
https://doaj.org/article/e5f7b5644b2c4637aa097989c3d41b58
Autor:
Gueiderikh, A., Ung, M., Lazarovici, J., Danu, A., Ghez, D., Saleh, K., Dragani, M., Noël, N., Bigenwald, C., Willekens, C., Ribrag, V., Michot, J.-M., Martin, V.
Publikováno v:
In Cancer / Radiothérapie September 2023 27(5):370-375
Autor:
Gueiderikh, A.1,2 (AUTHOR), Tarabay, A.1 (AUTHOR), Abdelouahab, M.3 (AUTHOR), Smolenschi, C.1,4 (AUTHOR), Tanguy, M. L.3 (AUTHOR), Valery, M.1 (AUTHOR), Malka, D.5 (AUTHOR), Pudlarz, T.1 (AUTHOR), Fuerea, A.1 (AUTHOR), Boige, V.1 (AUTHOR), Hollebecque, A.1,4 (AUTHOR), Ducreux, M.1,2 (AUTHOR), Boilève, A.1,2 (AUTHOR) alice.boileve@gustaveroussy.fr
Publikováno v:
BMC Cancer. 2/26/2024, Vol. 24 Issue 1, p1-9. 9p.
Autor:
Anna Gueiderikh, Thomas Sarrade, Youlia Kirova, Brigitte De La Lande, Florent De Vathaire, Guillaume Auzac, Anne Laure Martin, Sibille Everhard, Nicolas Meillan, Celine Bourgier, Ahmed Benyoucef, Thomas Lacornerie, David Pasquier, Séverine Racadot, Alexandra Moignier, François Paris, Fabrice André, Eric Deutsch, Boris Duchemann, Rodrigue Setcheou Allodji, Sofia Rivera
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeRadiation-induced lung injury (RILI) is strongly associated with various clinical conditions and dosimetric parameters. Former studies have led to reducing radiotherapy (RT) doses to the lung and have favored the discontinuation of tamoxifen d
Externí odkaz:
https://doaj.org/article/ea5a25b9b3ba4c42aa9f597be8748f8c
Autor:
Gueiderikh, Anna, Baude, Jérémy, Baron, David, Schiappa, Renaud, Katsahian, Sandrine, Moreau, Damien, Laurans, Marc, Bibault, Jean-Emmanuel, Kreps, Sarah, Bondiau, Pierre-Yves, Quivrin, Magali, Lépinoy, Alexis, Pasquier, David, Hannoun-Levi, Jean-Michel, Giraud, Philippe
Publikováno v:
Frontiers in Oncology; 2024, p1-10, 10p
Autor:
Renaudin, Xavier, Al Ahmad Nachar, Baraah, Mancini, Benedetta, Gueiderikh, Anna, Louis-Joseph, Noémie, Maczkowiak-Chartois, Frédérique, Rosselli, Filippo
Publikováno v:
PLoS Genetics; 11/7/2024, Vol. 20 Issue 11, p1-24, 24p
Publikováno v:
Genetics and Molecular Biology, Vol 40, Iss 2, Pp 398-407 (2017)
Abstract Among the chromosome fragility-associated human syndromes that present cancer predisposition, Fanconi anemia (FA) is unique due to its large genetic heterogeneity. To date, mutations in 21 genes have been associated with an FA or an FA-like
Externí odkaz:
https://doaj.org/article/98439dad01bd4133a99828208a679893
Autor:
A. Gueiderikh, M. Ung, J. Lazarovici, A. Danu, D. Ghez, K. Saleh, M. Dragani, N. Noël, C. Bigenwald, C. Willekens, V. Ribrag, J.-M. Michot, V. Martin
Publikováno v:
Cancer/Radiothérapie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30397d1f82c86a3b4afe662beb4f31a3
https://doi.org/10.1016/j.canrad.2023.04.004
https://doi.org/10.1016/j.canrad.2023.04.004